NewEdge Advisors’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
QCM
NewEdge Advisors's RCEL Position: Q2 2026 in Review
NewEdge Advisors increased its Avita Medical (RCEL) stake by 71% in Q2 2026, buying an estimated $268K and bringing the position to 148,931 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.
NewEdge Advisors first reported a position in RCEL in Q4 2024 and has held it in 7 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.
- NewEdge Advisors held 148,931 shares of Avita Medical worth $615K as of Q2 2026.
- NewEdge Advisors bought 62,046 Avita Medical shares in Q2 2026, an estimated $268K.
- Avita Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2008 holding.
- NewEdge Advisors first reported a position in Avita Medical in Q4 2024 and has held it in 7 quarters since.
- 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.